Pfizer (PFE) Misses Q4 EPS by 3c; Issues Lackluster Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.32 --0%
Revenue Growth %: -23.7%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Revenue Growth %: -23.7%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.47, $0.03 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $13.6 billion versus the consensus estimate of $13.64 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.50-$2.60, versus the consensus of $2.57. Pfizer sees FY2017 revenue of $52-54 billion, versus the consensus of $54 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
- Masco Corp. (MAS) Tops Q1 EPS by 5c; offers guidance
- Boston Scientific (BSX) Tops Q1 EPS by 5c; Guides Above Views
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
